Reference health

Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement

https://doi.org/10.1186/s12974-015-0464-8
CiteStamped reference-health badge
39/39 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 39 checked references that resolve
resolves10.1016/j.imbio.2012.07.024
The complement system in ischemia–reperfusion injuries
resolves10.3389/fimmu.2015.00417
Complement in the Homeostatic and Ischemic Brain
resolves10.4049/jimmunol.1201904
The Alternative Complement Pathway Propagates Inflammation and Injury in Murine Ischemic Stroke
resolves10.1161/CIRCULATIONAHA.112.103051
Targeting Mannose-Binding Lectin Confers Long-Lasting Protection With a Surprisingly Wide Therapeutic Window in Cerebral Ischemia
resolves10.1371/journal.pone.0008433
Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke
resolves10.2174/156720211794520260
The Contribution of Mannose Binding Lectin to Reperfusion Injury after Ischemic Stroke
resolves10.1002/ana.21740
Recombinant C1 inhibitor in brain ischemic injury
resolves10.1186/1742-2094-9-137
Complement activation in the injured central nervous system: another dual-edged sword?
resolves10.1385/MN:25:1:001
Roles of the Complement System in Human Neurodegenerative Disorders
resolves10.1007/s12975-011-0104-2
The Neuroprotective Effect of Genetic Mannose-Binding Lectin Deficiency Is Not Sustained in the Subacute Phase of Stroke
resolves10.1161/01.RES.0000232544.90675.42
Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia
resolves10.4049/jimmunol.177.10.7266
Complement-Dependent P-Selectin Expression and Injury following Ischemic Stroke
resolves10.1038/sj.emboj.7601004
Complement: a novel factor in basal and ischemia‐induced neurogenesis
resolves10.4049/jimmunol.181.11.8068
A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury
resolves10.1172/JCI25208
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection
resolves10.4049/jimmunol.160.9.4553
Blockade of Antibody-Induced Glomerulonephritis with Crry-Ig, a Soluble Murine Complement Inhibitor
resolves10.1097/00004647-199804000-00004
A Reproducible Model of Middle Cerebral Artery Occlusion in Mice: Hemodynamic, Biochemical, and Magnetic Resonance Imaging
resolves10.1016/j.bbr.2008.10.029
Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze
resolves10.1161/01.STR.17.6.1304
Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.
resolves10.1038/nbt1385
Direct multiplexed measurement of gene expression with color-coded probe pairs
resolves10.1016/S0306-4522(01)00117-8
Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia
resolves10.1002/stem.306
Subventricular Zone-Derived Neural Progenitor Cells Migrate Along a Blood Vessel Scaffold Toward The Post-stroke Striatum
resolves10.1371/journal.pone.0038664
Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke
resolves10.1073/pnas.182296499
Vascular endothelial growth factor (VEGF) stimulates neurogenesis <i>in vitro</i> and <i>in vivo</i>
resolves10.1111/j.1460-9568.2011.07610.x
Developmental dysregulation of adult neurogenesis
resolves10.1161/01.STR.31.6.1223
Medical Complications After Stroke
resolves10.1016/S0022-510X(99)00261-0
Fever and infection early after ischemic stroke
resolves10.1161/01.STR.0000109041.89959.4C
Preventive Antibacterial Treatment Improves the General Medical and Neurological Outcome in a Mouse Model of Stroke
resolves10.1186/1742-2094-5-5
Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo
resolves10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2
Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity
resolves10.1097/00001756-200102120-00022
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
resolves10.1096/fj.13-230011
Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic‐ischemic brain injury
resolves10.1523/JNEUROSCI.5249-09.2010
Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic–Ischemic Brain Injury
resolves10.1016/S0161-5890(01)00055-4
Complement and apoptosis
resolves10.1002/stem.225
Complement-Derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells
resolves10.1177/1753425910369271
Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation
resolves10.2174/187152711794488601
Activation and Control of CNS Innate Immune Responses in Health and Diseases: A Balancing Act Finely Tuned by Neuroimmune Regulators (NIReg)
resolves10.1073/pnas.0408835103
Drusen complement components C3a and C5a promote choroidal neovascularization
resolves10.1523/JNEUROSCI.3617-10.2011
<i>Complement Receptor 2</i>Is Expressed in Neural Progenitor Cells and Regulates Adult Hippocampal Neurogenesis
The 1 reference without a DOI — listed, not checked
no DOI — not checkedKomotar RJ, Kim GH, Otten ML, Hassid B, Mocco J, Sughrue ME, et al. The role of complement in stroke therapy. Adv Exp Med Biol. 2008;632:23–33.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1186/s12974-015-0464-8"><img src="https://citestamp.com/citestamped/10.1186/s12974-015-0464-8/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1186/s12974-015-0464-8/badge.svg)](https://citestamp.com/citestamped/10.1186/s12974-015-0464-8)